Brian M. Barth

2.9k total citations · 1 hit paper
38 papers, 2.2k citations indexed

About

Brian M. Barth is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Brian M. Barth has authored 38 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Physiology. Recurrent topics in Brian M. Barth's work include Sphingolipid Metabolism and Signaling (20 papers), Lipid Membrane Structure and Behavior (11 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Brian M. Barth is often cited by papers focused on Sphingolipid Metabolism and Signaling (20 papers), Lipid Membrane Structure and Behavior (11 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Brian M. Barth collaborates with scholars based in United States, India and Germany. Brian M. Barth's co-authors include Mark Kester, James M. Kaiser, James H. Adair, Erhan İ. Altınoğlu, P. C. Eklund, Timothy J. Russin, Joseph M. Rutkowski, William L. Holland, Kai Sun and Zhao V. Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Brian M. Barth

36 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin

2010 730 citations William L. Holland, Russell Miller et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian M. Barth United States	21	1.2k	505	482	435	241	38	2.2k
Ye Xu China	32	1.3k 1.1×	249 0.5×	476 1.0×	214 0.5×	253 1.0×	77	2.5k
Clara De Palma Italy	32	1.4k 1.2×	216 0.4×	332 0.7×	448 1.0×	220 0.9×	66	2.5k
Jong K. Yun United States	29	2.2k 1.9×	221 0.4×	410 0.9×	287 0.7×	159 0.7×	62	3.2k
Hyunseung Lee South Korea	31	1.1k 0.9×	404 0.8×	245 0.5×	121 0.3×	167 0.7×	107	2.5k
Todd E. Fox United States	34	2.2k 1.9×	305 0.6×	368 0.8×	394 0.9×	164 0.7×	83	3.1k
Zhenyu Yin China	32	1.8k 1.6×	319 0.6×	520 1.1×	192 0.4×	230 1.0×	87	3.2k
Jung Jin Hwang South Korea	27	1.4k 1.2×	179 0.4×	599 1.2×	276 0.6×	256 1.1×	75	2.7k
Qihua He China	32	1.4k 1.2×	216 0.4×	189 0.4×	251 0.6×	110 0.5×	111	3.1k
Zhihao Wu China	30	1.6k 1.3×	1.1k 2.1×	227 0.5×	270 0.6×	248 1.0×	101	3.5k
Dali Zheng China	29	2.0k 1.7×	419 0.8×	193 0.4×	285 0.7×	67 0.3×	91	3.1k

Countries citing papers authored by Brian M. Barth

Since Specialization

Citations

This map shows the geographic impact of Brian M. Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Barth more than expected).

Fields of papers citing papers by Brian M. Barth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Barth. The network helps show where Brian M. Barth may publish in the future.

Co-authorship network of co-authors of Brian M. Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Barth. A scholar is included among the top collaborators of Brian M. Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Barth. Brian M. Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barth, Brian M., et al.. (2021). Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2. NeuroMolecular Medicine. 23(1). 25–46. 16 indexed citations

Barth, Brian M., et al.. (2020). Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria. Scientific Reports. 10(1). 2003–2003. 153 indexed citations

Wang, Weiyuan, et al.. (2019). GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia. Blood. 134(Supplement_1). 1245–1245. 1 indexed citations

Wang, Weiyuan, Paul Toran, Rachel A. Sabol, Timothy J. Brown, & Brian M. Barth. (2018). Epigenetics and Sphingolipid Metabolism in Health and Disease. PubMed. 1(2). 6 indexed citations

Morad, Samy A.F., P. Darrell Neufer, Tonya N. Zeczycki, et al.. (2016). Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia. Journal of Lipid Research. 57(7). 1231–1242. 23 indexed citations

Matters, Gail L., Timothy K. Cooper, Christopher O. McGovern, et al.. (2014). Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat. Digestive Diseases and Sciences. 59(6). 1180–1191. 30 indexed citations

Doi, Kenichiro, Qiang Liu, Krishne Gowda, et al.. (2014). Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression. Cancer Biology & Therapy. 15(8). 1077–1086. 30 indexed citations

Young, Megan M., et al.. (2013). The Therapeutic Potential of Nanoscale Sphingolipid Technologies. Handbook of experimental pharmacology. 197–210. 9 indexed citations

Barth, Brian M., et al.. (2013). Gaucher's Disease and Cancer: A Sphingolipid Perspective. Critical Reviews™ in Oncogenesis. 18(3). 221–234. 26 indexed citations

10.

Ward, Katherine E., et al.. (2013). Ceramide 1-Phosphate Mediates Endothelial Cell Invasion via the Annexin a2-p11 Heterotetrameric Protein Complex. Journal of Biological Chemistry. 288(27). 19726–19738. 42 indexed citations

11.

Jiang, Yixing, Nicole A. DiVittore, James M. Kaiser, et al.. (2011). Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy. 12(7). 574–585. 57 indexed citations

12.

Barth, Brian M., et al.. (2011). Neutral sphingomyelinase activation precedes NADPH oxidase‐dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor‐α. Journal of Neuroscience Research. 90(1). 229–242. 44 indexed citations

13.

Barth, Brian M., et al.. (2011). Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells. Cellular Signalling. 24(6). 1126–1133. 22 indexed citations

14.

Fox, Todd E., et al.. (2011). Exogenous Ceramide-1-phosphate Reduces Lipopolysaccharide (LPS)-mediated Cytokine Expression. Journal of Biological Chemistry. 286(52). 44357–44366. 47 indexed citations

15.

Barth, Brian M., Myles C. Cabot, & Mark Kester. (2011). Ceramide-Based Therapeutics for the Treatment of Cancer. Anti-Cancer Agents in Medicinal Chemistry. 11(9). 911–919. 66 indexed citations

16.

DiVittore, Nicole A., Brian M. Barth, J. Kaiser, et al.. (2010). Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma. Gut. 60(5). 695–701. 68 indexed citations

17.

Holland, William L., Russell Miller, Zhao V. Wang, et al.. (2010). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine. 17(1). 55–63. 730 indexed citations breakdown →

18.

Gouazé‐Andersson, Valérie, Maria C. Messner, Margaret Flowers, et al.. (2010). Metabolism of short-chain ceramide by human cancer cells—Implications for therapeutic approaches. Biochemical Pharmacology. 80(3). 308–315. 45 indexed citations

19.

Barth, Brian M., Rahul Sharma, Erhan İ. Altınoğlu, et al.. (2010). Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo. ACS Nano. 4(3). 1279–1287. 113 indexed citations

20.

Barth, Brian M., et al.. (2009). Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Molecular and Cellular Neuroscience. 41(2). 274–285. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact